Literature DB >> 22938709

An animal model of endocardial fibroelastosis.

Ingeborg Friehs1, Ben Illigens, Ivan Melnychenko, Tachi Zhong-Hu, Elisabeth Zeisberg, Pedro J Del Nido.   

Abstract

BACKGROUND: Hypoplastic left heart syndrome (HLHS) is one of the most common severe congenital cardiac anomalies, characterized by a marked hypoplasia of left-sided structures of the heart, which is commonly accompanied by a thick layer of fibroelastic tissue, termed endocardial fibroelastosis (EFE). Because human EFE develops only in fetal or neonatal hearts, and often in association with reduced blood flow, we sought to mimic these conditions by subjecting neonatal and 2-wk-old rat hearts to variations of the heterotopically transplanted heart model with either no intracavitary or normal flow and compare endocardium with human EFE tissue.
MATERIALS AND METHODS: Hearts obtained from neonatal and 2-wk-old rats were heterotopically transplanted in young adult Lewis rats in a working (loaded) or nonworking (unloaded) mode. After 2-wk survival, hearts were explanted for histologic analysis by staining for collagen, elastin, and cellular elements. These sections were compared with human EFE tissue from HLHS.
RESULTS: EFE, consisting of collagen and elastin with scarce cellular and vascular components, developed only in neonatal unloaded transplanted hearts and displayed the same histopathologic findings as EFE from patients with HLHS. Loaded hearts and 2-wk-old hearts did not show these alterations.
CONCLUSIONS: This animal model for EFE will serve as a tool to study the mechanisms of EFE formation, such as fluid forces, in HLHS in a systematic manner. A better understanding of the underlying cause of the EFE formation in HLHS will help to develop novel treatment strategies to better preserve growth of the hypoplastic left ventricle.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22938709      PMCID: PMC3524408          DOI: 10.1016/j.jss.2012.07.069

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  23 in total

1.  THE TRANSPLANTED RAT HEART: HISTOLOGIC AND ELECTROCARDIOGRAPHIC CHANGES.

Authors:  C P ABBOTT; C W DEWITT; O CREECH
Journal:  Transplantation       Date:  1965-05       Impact factor: 4.939

2.  Endocardial fibroelastosis occurring in a mother and daughter.

Authors:  B Rios; P Castaneda; J W Simpson
Journal:  Tex Heart Inst J       Date:  1984-09

3.  Revisiting animal models of aortic stenosis in the early gestation fetus.

Authors:  Pirooz Eghtesady; Erik Michelfelder; Mekibib Altaye; Edgar Ballard; Russel Hirsh; Robert H Beekman
Journal:  Ann Thorac Surg       Date:  2007-02       Impact factor: 4.330

Review 4.  Sarcomere protein gene mutations and inherited heart disease: a beta-cardiac myosin heavy chain mutation causing endocardial fibroelastosis and heart failure.

Authors:  Mitsuhiro Kamisago; Joachim P Schmitt; Dennis McNamara; Christine Seidman; J G Seidman
Journal:  Novartis Found Symp       Date:  2006

5.  Animal model: pulmonary hypertension, cor pulmonale and endocardial fibroelastosis in monocrotaline-intoxicated nonhuman primates.

Authors:  C F Chesney; J R Allen
Journal:  Am J Pathol       Date:  1973-03       Impact factor: 4.307

6.  Assessment of left ventricular endocardial fibroelastosis in fetuses with aortic stenosis and evolving hypoplastic left heart syndrome.

Authors:  Doff B McElhinney; Melanie Vogel; Carol B Benson; Audrey C Marshall; Louise E Wilkins-Haug; Virginia Silva; Wayne Tworetzky
Journal:  Am J Cardiol       Date:  2010-12-15       Impact factor: 2.778

7.  Bisoprolol delays progression towards right heart failure in experimental pulmonary hypertension.

Authors:  Frances S de Man; M Louis Handoko; Joris J M van Ballegoij; Ingrid Schalij; Sylvia J P Bogaards; Pieter E Postmus; Jolanda van der Velden; Nico Westerhof; Walter J Paulus; Anton Vonk-Noordegraaf
Journal:  Circ Heart Fail       Date:  2011-12-09       Impact factor: 8.790

8.  Unexpected intrauterine fetal death in parvovirus B19 fetal infection.

Authors:  Enrico Silingardi; Anna Laura Santunione; Francesco Rivasi; Bernard Gasser; Silvia Zago; Lorella Garagnani
Journal:  Am J Forensic Med Pathol       Date:  2009-12       Impact factor: 0.921

9.  Serial noninvasive assessment of apoptosis during right ventricular disease progression in rats.

Authors:  Maria E Campian; Hein J Verberne; Maxim Hardziyenka; Kora de Bruin; Mariana Selwaness; Maurice J B van den Hoff; Jan M Ruijter; Berthe L F van Eck-Smit; Jacques M T de Bakker; Hanno L Tan
Journal:  J Nucl Med       Date:  2009-07-17       Impact factor: 10.057

10.  Endocardial fibroelastosis found on transvascular endomyocardial biospsy in children.

Authors:  H B Neustein; P R Lurie; M Fugita
Journal:  Arch Pathol Lab Med       Date:  1979-05       Impact factor: 5.534

View more
  10 in total

1.  Fibroblasts in an endocardial fibroelastosis disease model mainly originate from mesenchymal derivatives of epicardium.

Authors:  Hui Zhang; Xiuzhen Huang; Kuo Liu; Juan Tang; Lingjuan He; Wenjuan Pu; Qiaozhen Liu; Yan Li; Xueying Tian; Yue Wang; Libo Zhang; Ying Yu; Hongyan Wang; Ronggui Hu; Fengchao Wang; Ting Chen; Qing-Dong Wang; Zengyong Qiao; Li Zhang; Kathy O Lui; Bin Zhou
Journal:  Cell Res       Date:  2017-08-15       Impact factor: 25.617

2.  Endocardial fibroelastosis is caused by aberrant endothelial to mesenchymal transition.

Authors:  Xingbo Xu; Ingeborg Friehs; Tachi Zhong Hu; Ivan Melnychenko; Björn Tampe; Fouzi Alnour; Maria Iascone; Raghu Kalluri; Michael Zeisberg; Pedro J Del Nido; Elisabeth M Zeisberg
Journal:  Circ Res       Date:  2015-01-13       Impact factor: 17.367

Review 3.  Endothelial to Mesenchymal Transition in Cardiovascular Disease: JACC State-of-the-Art Review.

Authors:  Jason C Kovacic; Stefanie Dimmeler; Richard P Harvey; Toren Finkel; Elena Aikawa; Guido Krenning; Andrew H Baker
Journal:  J Am Coll Cardiol       Date:  2019-01-22       Impact factor: 24.094

Review 4.  Probing single ventricle heart defects with patient-derived induced pluripotent stem cells and emerging technologies.

Authors:  Bailey Hall; Matthew Alonzo; Karen Texter; Vidu Garg; Ming-Tao Zhao
Journal:  Birth Defects Res       Date:  2022-02-24       Impact factor: 2.661

Review 5.  Cellular mechanisms of tissue fibrosis. 1. Common and organ-specific mechanisms associated with tissue fibrosis.

Authors:  Michael Zeisberg; Raghu Kalluri
Journal:  Am J Physiol Cell Physiol       Date:  2012-12-19       Impact factor: 4.249

6.  A mouse model of endocardial fibroelastosis.

Authors:  Elizabeth S Clark; Victoria K Pepper; Cameron A Best; Ekene A Onwuka; Tai Yi; Shuhei Tara; Rachel Cianciolo; Peter Baker; Toshiharu Shinoka; Christopher K Breuer
Journal:  Cardiovasc Pathol       Date:  2015-08-08       Impact factor: 2.185

7.  Distention of the Immature Left Ventricle Triggers Development of Endocardial Fibroelastosis: An Animal Model of Endocardial Fibroelastosis Introducing Morphopathological Features of Evolving Fetal Hypoplastic Left Heart Syndrome.

Authors:  Shogo Shimada; Christian Robles; Ben M W Illigens; Alejandra M Casar Berazaluce; Pedro J del Nido; Ingeborg Friehs
Journal:  Biomed Res Int       Date:  2015-05-03       Impact factor: 3.411

Review 8.  Hypoplastic left heart syndrome - unresolved issues.

Authors:  Raoul Roman Arnold; Tsvetomir Loukanov; Matthias Gorenflo
Journal:  Front Pediatr       Date:  2014-11-10       Impact factor: 3.418

9.  Abnormal Flow Conditions Promote Endocardial Fibroelastosis Via Endothelial-to-Mesenchymal Transition, Which Is Responsive to Losartan Treatment.

Authors:  Nicholas A Oh; Xuechong Hong; Ilias P Doulamis; Elamaran Meibalan; Teresa Peiseler; Juan Melero-Martin; Guillermo García-Cardeña; Pedro J Del Nido; Ingeborg Friehs
Journal:  JACC Basic Transl Sci       Date:  2021-12-27

10.  Concurrent occurrence of acute bovine pulmonary edema and emphysema and endocardial fibroelastosis in cattle: A case history and literature review.

Authors:  W M Hananeh; Z B Ismail
Journal:  Vet World       Date:  2018-07-21
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.